{
  "id": "9e80b443c07ca16d",
  "title": "Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification",
  "description": "20260130T221500Z",
  "content": "",
  "source": "prnewswire.com",
  "source_url": "https://www.prnewswire.com/news-releases/galmed-pharmaceuticals-announces-receipt-of-nasdaq-minimum-bid-price-notification-302674968.html",
  "published_at": "20260130T221500Z",
  "fetched_at": "2026-01-31T00:26:46.418942+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.prnewswire.com/news-releases/galmed-pharmaceuticals-announces-receipt-of-nasdaq-minimum-bid-price-notification-302674968.html",
    "url_mobile": "",
    "title": "Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification",
    "seendate": "20260130T221500Z",
    "socialimage": "",
    "domain": "prnewswire.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}